On May 26, 2020 Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, reported that Bassil Dahiyat, Ph.D., president and chief executive officer, will participate in two upcoming investor conferences (Press release, Xencor, MAY 26, 2020, View Source [SID1234558494]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Jefferies Virtual Healthcare Conference
Date: Tuesday, June 2, 2020
Presentation Time: 2:30 p.m. ET / 11:30 a.m. PT
Raymond James Human Health Innovation Conference
Date: Monday, June 15, 2020
Immuno-Oncology Panel Time: 11:00 a.m. ET / 8:00 a.m. PT
A live webcast of the presentation at the Jefferies conference will be available under "Events & Presentations" in the Investors section of the Company’s website located at www.xencor.com. A replay will be posted on the Xencor website approximately one hour after the live event and will be available for 30 days.